ArticleClinical and molecular hepatology2022

Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis.

Joonho Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.